----

----

----

----

| Nevada                                                              |   | 95-4696799                           |
|---------------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

|  Large accelerated filer       ̈         |  Accelerated filer                       ̈ |
|-----------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|
|  Non-accelerated filer         ̈         |  Smaller reporting company   x                                                                                                           |
|  (Do not check if a smaller reporting company)         |                                                                                                                                                    |

----

Table of Contents

TABLE 

|                         | Page                                                                                  |
|------------------------------|---------------------------------------------------------------------------------------|
| Part I Financial Information |                                                                                  |
|                         |                                                                                  |   |   |
| Item 1.                      | Financial Statements                                                                  | 3 |
|                         |                                                                                  | Condensed Consolidated Balance Sheet as of September 30, 2010 (unaudited) and June 30, 2010 (audited) | 4 |
|                         |                                                                                  | Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2010 and 2009 (unaudited) | 5 |
|                         |                                                                                  | Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2010 and 2009 (unaudited) | 6 |
|                         |                                                                                  | Notes to Condensed Consolidated Financial Statements (unaudited) |   |
|                         |                                                                                  |   |   |
| Item 2.                      | Management's Discussion and Analysis of Financial Condition and Results of Operations | 9 |
|                         |                                                                                  |   |   |
| Item 3.                      | Quantitative and Qualitative Disclosure About Market Risk                             | 13 |
|                         |                                                                                  |   |   |
| Item 4T.                     | Controls and Procedures                                                               | 13 |
|                         |                                                                                  |   |   |
| Part II Other Information    |                                                                                  |
|                         |                                                                                  |   |   |
| Item 2.                      | Unregistered Sales of Equity Securities and Use of Proceeds                           | 14 |
|                         |                                                                                  |   |   |
| Item 5.                      | Other Information                                                                     | 14 |
|                         |                                                                                  |   |   |
| Item 6.                      | Exhibits                                                                              | 14 |
|                         |                                                                                  |   |   |
|                         | Signatures                                                                            | 15 |

----

Table of Contents

ITEM 

IMEDICOR

|                                                                                                                                                                               |   | Sept 30, 2010 |        |   | June 30, 2010 |   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------|-------------|--------|---------------|--------|
|                                                                                                                                                                               |   | (unaudited)   |        |   | (audited)     |   |
| ASSETS                                                                                                                                                                             |   |          |        |   |          |   |
| Current assets:                                                                                                                                                                    |   |          |        |   |          |   |
| Cash and cash equivalents                                                                                                                                                          |   | $             | 21,614      |   |          | $      | 86,644 |   |
| Accounts receivable, net of allowance for doubtful accounts of $-0-     at September 30, 2010 and June 30, 2010, respectively                                  |   |          | 54,340      |   |          |   | 10,000 |   |
| Prepaid Expenses                                                                                                                                                                   |   |          | 4,011       |   |          |   | 6,001 |   |
| Total Current Assets                                                                                                                                                               |   |          | 79,965      |   |          |   | 102,645 |   |
| Property and equipment, net                                                                                                                                                        |   |          | 6,870       |   |          |   | 8,291 |   |
| Other Assets                                                                                                                                                                       |   |          |        |   |          |   |   |   |
| Technology and Medical Software, net                                                                                                                                               |   |          | 4,537,090   |   |          |   | 4,996,785 |   |
|                                                                                                                                                                               |   |          | 4,537,090   |   |          |   | 4,996,785 |   |
| Total Assets                                                                                                                                                                       |   | $             | 4,623,925   |   |          | $      | 5,107,721 |   |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                                                                                                                               |   |          |        |   |          |   |   |   |
| Current liabilities:                                                                                                                                                               |   |          |        |   |          |   |   |   |
| Notes payable –– banks                                                                                                                                                 |   | $             | 37,516      |   |          | $      | 59,181 |   |
| Short-term notes payable                                                                                                                                                           |   |          | 6,939,346   |   |          |   | 5,487,120 |   |
| Accounts payable and accrued expenses                                                                                                                                              |   |          | 1,746,919   |   |          |   | 1,791,671 |   |
| Deferred income                                                                                                                                                                    |   |          | 60,000      |   |          |   | 60,000 |   |
| Total Current Liabilities                                                                                                                                                          |   |          | 8,783,781   |   |          |   | 7,397,972 |   |
| Other long-term liabilities                                                                                                                                                        |   |          |        |   |          |   |   |   |
| Long-term notes payable                                                                                                                                                            |   |          | -           |   |          |   | 1,271,661 |   |
| Total Liabilities                                                                                                                                                                  |   |          | 8,783,781   |   |          |   | 8,669,663 |   |
| Stockholders’ Equity (Deficit)                                                                                                                                               |   |          |        |   |          |   |   |   |
| Preferred stock, par value $.001, authorized 200,000,000. Issued and outstanding-0- shares   As of Sept 30, 2010 and June 30, 2010, respectively                              |   |          |        |   |          |   |   |   |
| Common stock, par value $.001 per share, authorized 600,000,000. Issued and outstanding:   253,761,124 and 229,082,190 shares at Sept 30, 2010 and June 30 2010, respectively |   |          | 253,761     |   |          |   | 229,082 |   |
| Additional Paid in Capital                                                                                                                                                         |   |          | 38,838,420  |   |          |   | 37,849,158 |   |
| Less: Treasury stock, 368,407 shares at both September 30, 2010 and June 30, 2010                                                                                                  |   |          | (508,195    | )      |          |   | (508,195 | ) |
| Accumulated deficit                                                                                                                                                                |   |          | (42,743,842 | )      |          |   | (41,131,957 | ) |
| Total Stockholders’ Equity (Deficit)                                                                                                                                         |   |          | (4,159,856  | )      |          |   | (3,561,912 | ) |
| Total Liabilities and Stockholders’ Equity (Deficit)                                                                                                                         |   | $             | 4,623,925   |   |          | $      | 5,107,721 |   |

----

Table of Contents

IMEDICOR

|                                                             |   | For the three      |        |   | For the three      |    |
|------------------------------------------------------------------|--------|--------------------|-------------|--------|--------------------|---------|
|                                                             |   | months ended       |        |   | months ended       |    |
|                                                             |   | September 30, 2010 |        |   | September 30, 2009 |    |
|                                                             |   | (unaudited)        |        |   | (unaudited)        |    |
|                                                             |   |               |        |   |               |    |
| Revenues:                                                        |   | $                  | 48,597      |   |               | $       | 65,832 |   |
| Cost of Services                                                 |   |               | 1,212       |   |               |    | 10,995 |   |
| Gross Profit                                                     |   |               | 47,385      |   |               |    | 54,837 |   |
|  Expenses:                                                  |   |               |        |   |               |    |   |   |
| Stock issued for fees and services                               |   |               | 260,612     |   |               |    | 1,231,530 |   |
| Consulting, commissions and travel                               |   |               | 66,363      |   |               |    | 88,764 |   |
| Operational fees and expenses                                    |   |               | 143,737     |   |               |    | 177,922 |   |
| Professional fees                                                |   |               | 13,000      |   |               |    | 105,375 |   |
| Payroll and related taxes                                        |   |               | 180,566     |   |               |    | 223,015 |   |
| Depreciation and amortization                                    |   |               | 516,116     |   |               |    | 503,437 |   |
| Production, advertising, brochures and public relations          |   |               | 20,925      |   |               |    | 62,279 |   |
| Total Expenses                                                   |   |               | 1,231,319   |   |               |    | 2,392,322 |   |
| Loss before other expenses                                       |   |               | (1,183,934  | )      |               |    | (2,337,485 | ) |
|  Other Income/(Expenses):                                   |   |               |        |   |               |    |   |   |
| Other expense – Redemption fee expense                     |   |               | -           |   |               |    | (148,146) |   |
| Interest expense                                                 |   |               | (241,951    | )      |               |    | (130,097 | ) |
| Total Other Income/(Expenses)                                    |   |               | (241,951    | )      |               |    | (278,243 | ) |
|                                                             |   |               |        |   |               |    |   |   |
| Loss before dividend                                             |   | $                  | (1,425,885  | )      |               | $       | (2,615,728 | ) |
| Dividends related to warrants issued                        |   |               | 186,000     |   |               |    | - |   |
| Net loss available to common stockholders                        |   | $                  | (1,611,885  | )      |               | $       | (2,615,728 | ) |
|                                                             |   |               |        |   |               |    |   |   |
| Net loss per share, basic and diluted, before extraordinary item |   | $             | (0.01       | )      |               | $  | (0.01 | ) |
| Net loss per share, basic and diluted, extraordinary item net    |   |               | -           |   |               |    | - |   |
| Net loss per share, to common stockholders                       |   | $                  | (0.01       | )      |               | $       | (0.01 | ) |
| Weighted average number of shares, basic and diluted             |   |               | 235,025,314 |   |               |    | 122,961,154 |   |

----

Table of Contents

IMEDICOR

|                                          |   | For the three      |      |    | For the three      |   |
|-----------------------------------------------|--------|--------------------|-----------|---------|--------------------|--------|
|                                          |   | months ended       |      |    | months ended       |   |
|                                          |   | September 30, 2010 |      |    | September 30, 2009 |   |
|                                          |   | (unaudited)        |      |    | (unaudited)        |   |
| Cash Flows From Operating Activities:         |   |               |      |    |               |   |
| Receipts from customers                       |   | $                  | 4,257     |    |               | $      | 65,832 |   |
| Payments to suppliers, salaries               |   |               | (468,564  | )       |               |   | (612,740 | ) |
| Interest received                             |   |               | -         |    |               |   | - |   |
| Interest paid                                 |   |               | (178,058) |    |               |   | 42,468 |   |
| Net Cash Used in Operating Activities         |   |               | (642,635  | )       |               |   | (504,440 | ) |
|                                          |   |               |      |    |               |   |   |   |
| Cash Flows Used in Investing Activities:      |   |               |      |    |               |   |   |   |
| Purchase of Technology & Medical Software |   |               | (55,000   | )  |               |   | - |   |
|                                          |   |               |      |    |               |   |   |   |
| Net Cash Used in Investing Activities         |   |               | (55,000   | )  |               |   | - |   |
|                                          |   |               |      |    |               |   |   |   |
| Cash Flows From Financing Activities:         |   |               |      |    |               |   |   |   |
| Payments on notes payable                     |   |               | (21,665   | )       |               |   | (15,000 | ) |
| Short term loans proceeds                     |   |               | 170,000   |    |               |   | 470,000 |   |
| Sale of  common stock               |   |               | 484,000   |    |               |   | - |   |
| Net Cash Provided by Financing Activities     |   |               | 632,335   |    |               |   | 455,000 |   |
|                                          |   |               |      |    |               |   |   |   |
| Net Increase/(Decrease) in Cash               |   |               | (65,030   | )       |               |   | (49,440 | ) |
|                                          |   |               |      |    |               |   |   |   |
| Cash at the Beginning of Period               |   |               | 86,644    |    |               |   | 52,615 |   |
|                                          |   |               |      |    |               |   |   |   |
| Cash at End of Period                         |   | $                  | 21,614    |    |               | $      | 3,175 |   |

|                                                                                                 |   |    |          |    |   |    |
|------------------------------------------------------------------------------------------------------|--------|---------|---------------|---------|--------|---------|
| Reconciliation of Net Loss to Net Cash                                                               |   |    |          |    |   |    |
|      Used by Operating Activities                                           |   |    |          |    |   |    |
| Net Loss                                                                                             |   | $       | (1,611,885    | )       |   | $       | (2,615,708 | ) |
| Adjustments to Reconcile net income/(loss) to net cash                                               |   |    |          |    |   |    |   |   |
|         Used by operating activities                         |   |    |          |    |   |    |   |   |
| Stock issued for fees and services                                                                   |   |    | 290,612       |    |   |    | 1,231,530 |   |
| Depreciation & Amortization                                                                      |   |    | 516,116       |    |   |    | 503,437 |   |
| Dividends related to warrants issued                                                            |   |    |  186,000 |    |   |    |  - |   |
| Changes in:                                                                                          |   |    |          |    |   |    |   |   |
| Trade receivables                                                                                    |   |    | (44,340       | )  |   |    | - |   |
| Other receivables                                                                                    |   |    | -             |    |   |    | - |   |
| Accounts payable and accrued expenses                                                                |   |    | (44,752       | )  |   |    | 105,781 |   |
| Prepaid expenses                                                                           |   |    | 1,990         |    |   |    |  - |   |
| Accrued interest payable                                                                             |   |    | 63,894        |    |   |    | 271,330 |   |
| Deferred income                                                                                      |   |    | -             |    |   |    | (810 | ) |
|      Net Cash Used in Operating Activities                             |   | $       | (642,365      | )  |   | $       | (504,440 | ) |
|                                                                                                 |   |    |          |    |   |    |   |   |
| Supplemental disclosures                                                                             |   |    |          |    |   |    |   |   |
|    Schedule of Noncash Investing and Financing Transactions                           |   |    |          |    |   |    |   |   |
|        Stock issued for fees and services                         |   |  $ | 290,612  |    |   |  $ | 1,231,520 |   |
|        Stock exchanged for note payable and accrued interest |   |    | -             |    |   |    | 2,448,013 |   |
|        Income derived from relinquishment of debt                 |   |    | -             |    |   |    | (270,000 | )  |
|        Stock issued for legal settlement                          |   |    | -             |    |   |    | 195,500 |   |
|        Stock issued for vendor payable                       |   |    | -             |    |   |    | 65,500 |   |

----

Table of Contents

IMEDICOR

----

Table of Contents

| No. Shares           |       |   |       |   |              |           |   |
|----------------------|------------|--------|------------|--------|-------------------|----------------|--------|
| Issuable on Exercise |       |   | Expiration |   |              | Exercise Price |   |
|                 | 1,239,999  |   |       |   | 2011              |           |   | $ | 0.60 |   |
|                 | 1,430,000  |   |       |   | 2011              |           |   | $ | 0.24 |   |
|                 | 1,541,667  |   |       |   | 2011              |           |   | $ | 0.12 |   |
|                 | 4,000,000  |   |       |   | 2013              |           |   | $ | 0.04 |   |
|                 | 13,640,000 |   |       |   | 2013              |           |   | $ | 0.03 |   |
|                 | 16,160,000 |   |       |   | 2013 – 2015 |           |   | $ | 0.05 |   |
|                 |       |   |       |   |              |           |   |   |   |   |

----

Table of Contents

|                                                               |   | 9/30/2010 |       |   | 6/30/2010 |   |
|--------------------------------------------------------------------|--------|-----------|------------|--------|-----------|--------|
| Technology and medical software                               |   | $         | 10,293,893 |   |      | $      | 10,238,892 |   |
| Less: Accumulated Amortization       |   |      | 5,756,803  |   |      |   | 5,242,107 |   |
|                                                               |   | $         | 4,537,090  |   |      | $      | 4,996,785 |   |

| Convertible Debentures               |   | $      | 5,014,344  |    |
|--------------------------------------|--------|--------|------------|---------|
| Notes Payable                        |   |   | 1,925,002  |    |
| Total                                |   | $      | 6,939,346  |    |
| Less: portion in current liabilities |   |   | (6,939,346 | )  |
| Balance of long term debt            |   | $      | 0          |    |
|                                 |   |   |       |    |
| Long term debt matures as follows:   |   |   |       |    |
| September 30, 2011              |   | $      | 6,939,346  |    |

----

Table of Contents

ITEM 

----

Table of Contents

----

Table of Contents

|                                            |   | Three Months Ended September 30 |        |
|-------------------------------------------------|--------|---------------------------------|-------------|
|                                            |   | (unaudited)                     |        |
|                                            |   | 2010                            |        |   | 2009 |   |
| Net Sales and Revenues                          |   | $                               | 48,597      |   |   | $ | 65,832 |   |
| Cost of Services                                |   |                            | 1,212       |   |   |   | 10,995 |   |
| Gross Profit                                    |   |                            | 47,385      |   |   |   | 54,837 |   |
|                                            |   |                            |        |   |   |   |   |   |
| Operational General and Administrative Expenses |   |                            | 424,591     |   |   |   | 657,355 |   |
| Depreciation and amortization                   |   |                            | 516,116     |   |   |   | 503,437 |   |
| Stock issued for fees and services              |   |                            | 290,612     |   |   |   | 1,231,530  |   |
| Total Expenses                                  |   |                            | 1,231,319   |   |   |   | 2,392,322 |   |
| Loss before other income (expense)              |   | $                               | (1,183,934) |   |   | $ | (2,337,485 | ) |

----

Table of Contents

----

Table of Contents

ITEM 

ITEM 

----

Table of Contents

ITEM 

ITEM 

ITEM 

| 31.1 | Certification of the President and Chief Executive Officer pursuant to Rule 13a-14(a). |
|------|----------------------------------------------------------------------------------------|

| 31.2 | Certification of the Chief Financial Officer and Treasurer pursuant to Rule 13a-14(a). |
|------|----------------------------------------------------------------------------------------|

| 32 | Certification of the President and Chief Executive Officer and Chief Financial Officer and Treasurer pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

SIGNATURES

|                    | IMedicor, Inc.(Registrant) |                                                               |
|-------------------------|----------------------------|--------------------------------------------------------------------|
|                    |                       |                                                               |   |
| Date: November 19, 2010 | By:                        | /s/ Fred Zolla                                                |   |
|                    |                       | Fred Zolla                                                         |   |
|                    |                       | President and Chief Executive Officer(Principal Executive Officer) |   |
|                    |                       |                                                               |   |

| Date: November 19, 2010 | By:    | /s/ Craig Stout                                          |   |
|-------------------------|--------|---------------------------------------------------------------|--------|
|                    |   | Craig Stout                                                   |   |
|                    |   | Interim Chief Financial Officer(Principal Accounting Officer) |   |
|                    |   |                                                          |   |

----

Table of Contents